Technical analysis of Minerva Neurosciences, Inc. (NERV): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system.
Price Performance
| 1 month | -23.13% |
| 3 months | -21.92% |
| Year-to-date | -13.18% |
| 1 year | +63.08% |
| 3 years | -55.82% |
| 5 years | -74.34% |
52-Week Range
| 52-week High | $12.46 |
| 52-week Low | $1.93 |
| Avg Volume (90d) | 222K |
Technical Indicators
| SMA 50 | $4.39 |
| SMA 200 | $5.08 |
| Beta | -0.21 |
| 30-day Volatility (annualised) | 89.7% |
| Price vs SMA 50 | -20.4% |
| Price vs SMA 200 | -31.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $4.20 | |
| 2025-11 | $4.18 | -0.5% |
| 2025-12 | $4.02 | -3.8% |
| 2026-01 | $4.06 | +1.0% |
| 2026-02 | $6.60 | +62.6% |
| 2026-03 | $6.03 | -8.6% |
| 2026-04 | $6.47 | +7.3% |
| 2026-05 | $4.91 | -24.1% |
| 2026-06 | $5.55 | +13.0% |
| 2026-07 | $3.98 | -28.3% |
| 2026-08 | $4.56 | +14.6% |
| 2026-09 | $3.49 | -23.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $3.48 |
| Market Cap | $162M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -0.78 |
| EV / EBITDA | -0.46 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 20.14 |